Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women
about
Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease PreventionPrevalence of the most frequent BRCA1 mutations in Polish populationCurrent guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriersClinical management of hereditary breast cancer syndromes.Personalized medicine: a personal viewPopulation-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.Re. Multimodality breast cancer screening in women with a familial or genetic predisposition.Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trialCost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testingCase report: BRCA in the Ashkenazi population: are current testing guidelines too exclusive?Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancerIs it time to offer BRCA1 and BRCA2 testing to all Jewish women?Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases.Searching for the noninvasive biomarker holy grail: are urine proteomics the answer?Dealing with the unexpected: consumer responses to direct-access BRCA mutation testingHigh Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic CounselingManagement of the asymptomatic BRCA mutation carrier.Hereditary breast cancer in the Han Chinese population.A comparison of the detection of BRCA mutation carriers through the provision of Jewish population-based genetic testing compared with clinic-based genetic testing.Genetic tests to identify risk for breast cancer.Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.Inherited mutations in breast cancer genes--risk and response.Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer.Opportunities and hurdles in the treatment of BRCA1-related breast cancer.Hereditary breast cancer syndromes and genetic testing.Use of BRCA Mutation Test in the U.S., 2004-2014.Genetic screening for gynecological cancer: where are we heading?Advances in Hereditary Colorectal and Pancreatic Cancers.The Impact of Angelina Jolie (AJ)'s Story on Genetic Referral and Testing at an Academic Cancer Centre in Canada.Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations.Prevalence of founder mutations in the BRCA1 and BRCA2 genes among unaffected women from the Bahamas.The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas.Screening for BRCA1 and BRCA2 mutations among French-Canadian breast cancer cases attending an outpatient clinic in Montreal.Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral.Population screening for BRCA1/BRCA2 mutations: lessons from qualitative analysis of the screening experience.Experiences from a pilot program bringing BRCA1/2 genetic screening to theUS Ashkenazi Jewish population.Cultural aspects of healthy BRCA carriers from two ethnocultural groups.A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago.BRCA genetic testing of individuals from families with low prevalence of cancer: experiences of carriers and implications for population screening.
P2860
Q26744525-9A9AB3A5-B811-4195-AD36-DF1FCA425956Q28390186-6B716058-6C51-412A-803F-B52E043F1B76Q33823472-C514B1EC-4412-45CD-9C4E-4EE0032E44FCQ34167563-3796ED4E-5D89-436A-8E90-40911079DB7FQ34171954-A7DB5225-1334-49F6-85F3-D46494B5B55EQ34314370-E3DBCA14-5501-4F36-99F6-1BAFD9A1A69FQ34359388-169A589F-7A29-4FB6-A690-CD296309CB97Q34994568-A41D53A1-836D-43C7-880D-B9AE7E16BC4EQ34994574-63B5A079-C975-4445-A991-2EA625C9BA9CQ35137548-F6EC6796-108B-4C7E-8F19-A47FBE6DED0EQ35830539-AD5F194E-D180-43E8-BB99-EEFFE2DE9DEEQ35934272-5CFD8091-AE26-45F3-90B0-8EB39B6CF1E2Q35998356-1D11AC7B-89B4-4C19-8F23-DAEE97243730Q36394369-BF1CD435-24A8-4143-958D-DDEDE0D90171Q36601626-F0F11366-E9A9-4C06-8B81-B4DD4532EB76Q36773744-A2AB9626-2DF6-4D13-AAF4-A6F8093FDF39Q36906183-E0BB7BC3-84D2-47D6-8358-9F00A2F452BFQ36925172-52D0A13F-F82D-44A9-A957-1DBCC3999E30Q36978755-DBB4190E-6A05-4586-AEF5-E4C47CF59AE0Q37081830-94C61DA5-97C6-4082-8290-BA1280D8C185Q37207327-8494B899-22C7-44DC-9190-366E390A6A4EQ37585888-858FB78D-7639-4AC0-BAC7-A6FA9AE2FDACQ37861028-39E9AAA6-D277-47FE-B6C9-79437B043E3FQ37877648-08FB25B5-F29F-410D-9F99-12A3A2919D4AQ38129725-A63D7425-90DC-4012-86FE-57C16DAA8399Q38266306-5914C374-EE95-400F-AC32-F4D8CCA3E402Q38371909-F37B17AA-C6CE-442D-B744-68E379729CD8Q38659935-A71AEDDD-D88E-4ACC-A16F-8A135582324EQ38798530-1D94D15F-8C76-48F7-BAC2-AFDB5C5C540DQ38845114-BD2742EF-06EC-4DE8-ADA8-85226EE7F40EQ39209421-058D9D48-5DFF-4505-A9AB-7CF0EC76327BQ41004174-2EA2800B-7942-4F4F-B305-6F3EE7CC0388Q43702401-77CB7A7D-4FF3-4D0C-B552-BBBBF8547767Q44746809-10A63E65-7706-452C-B990-DFB6EEC9E100Q47251083-6F4584E9-8E2B-4C28-B1EE-4B06872B2DE7Q47252765-39BDFEAB-E19A-4108-8883-959DE8594F9DQ47393855-590B138E-68AE-4561-8492-84850A1EEF79Q47656975-56971F35-372F-40F4-B24E-1C41ECE94E5CQ48137434-C0EBA63B-E4FE-443B-910B-FD3DFEB7A1CAQ50583763-772A3165-3D6F-4159-B287-96E3AE305E67
P2860
Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women
description
article
@en
im Januar 2010 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2010
@uk
name
Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women
@en
Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women
@nl
type
label
Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women
@en
Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women
@nl
prefLabel
Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women
@en
Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women
@nl
P2093
P356
P1476
Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women
@en
P2093
Aletta Poll
Anna Tulman
Kelly A Metcalfe
Marcia Llacuachaqui
Robert Royer
P304
P356
10.1200/JCO.2009.25.0712
P407
P577
2010-01-20T00:00:00Z